GMED Company Profile and Key Details

Q: Who are the executives of GMED?

Mr. Mike ReederExecutive OfficerMr. Richard HolifieldExecutive OfficerMr. A. Brett MurphyExecutive Vice President of International SalesMr. Steven M. PayneVice President & ControllerMr. John DowlingExecutive OfficerMr. David C. PaulCo-Founder & Executive ChairmanMs. Kelly G. Huller Esq.Senior Vice President, Gen. Counsel & Sec.Mr. Brian J. KearnsSenior Vice President of Bus. Devel. & Investor RelationsMr. Daniel T. ScavillaPres, Chief Executive Officer & DirectorMr. Keith W. PfeilSenior Vice President & Chief Financial Officer

NYSE : GMED

Globus Medical

$87.92

0.18+0.21%

At Close 4:00 PM

54.46

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Globus Medical, Inc. (GMED) stock surged +0.21%, trading at $87.92 on NYSE, up from the previous close of $87.74. The stock opened at $85.86, fluctuating between $84.98 and $90.43 in the recent session.

Stock Snapshot

87.74

Prev. Close

11.89B

Market Cap

84.98

Day Low

22.43

P/E Ratio

3.92

EPS (TTM)

1.2

Cash Flow per Share

85.86

Open

135.25M

Number of Shares

90.43

Day High

99.29%

Free Float in %

Book Value

888.51K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	86.17	90.43	84.98	87.92	888.51K
Apr 01, 2026	86.27	88.62	85.52	87.74	1.35M
Mar 31, 2026	84.53	87.39	83.57	86.16	1.5M
Mar 30, 2026	84.51	84.51	82.29	83.51	914.55K
Mar 27, 2026	85.72	85.72	82.01	83.78	982.7K
Mar 25, 2026	86.63	87.70	85.42	87.35	717.52K
Mar 24, 2026	85.91	87.18	85.62	86.25	1.01M
Mar 23, 2026	87.63	88.36	86.84	87.21	776.05K
Mar 20, 2026	86.19	86.50	84.66	86.26	1.48M
Mar 19, 2026	85.86	87.03	85.11	86.30	816.62K
Mar 18, 2026	87.54	87.89	86.53	86.58	971.43K
Mar 17, 2026	87.09	88.38	86.53	88.16	1.02M
Mar 16, 2026	85.80	86.38	85.21	85.76	794.03K
Mar 13, 2026	85.14	86.75	84.64	84.77	1.22M
Mar 12, 2026	86.04	87.71	84.48	84.51	844.85K
Mar 11, 2026	86.25	87.40	85.01	87.17	1.09M
Mar 10, 2026	88.51	88.51	86.13	86.65	971.64K
Mar 09, 2026	86.05	88.04	84.34	87.81	847.97K
Mar 06, 2026	87.67	87.79	85.55	87.10	703.79K
Mar 03, 2026	91.62	92.19	89.65	91.70	819.12K

Contact Details

Audubon, PA 19403

United States

https://www.globusmedical.com 610 930 1800

About Company

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Stock Peers

SYK

2.14+0.65%

Stryker Corporation$331.54 PEN

1.4+0.43%

Penumbra, Inc.$330.36 BIO-B

2.05+0.74%

Bio-Rad Laboratories, Inc.$280.30 BIO

1.63+0.59%

Bio-Rad Laboratories, Inc.$279.99 STE

-1.23-0.56%

STERIS plc$218.71 GKOS

0.13+0.12%

Glaukos Corporation$112.77 ABT

0.49+0.48%

Abbott Laboratories$102.87 ZBH

-0.14-0.15%

Zimmer Biomet Holdings, Inc.$90.89 ITGR

0.41+0.47%

Integer Holdings Corporation$86.85 MDT

0.57+0.66%

Medtronic plc$86.63

Company Overview

Globus Medical, Inc. (NYSE:GMED) closed at $87.92 USD, gaining $0.18 (0.21%) from the previous close of $87.74. The stock is currently mid-range between its 52-week high and low $51.79 and $101.40. With a market capitalization of about $11.89 billion, Globus Medical, Inc. is classified as a large-cap and shows market-like volatility (beta ~1.07). Key stats such as the average daily volume over the past year has been around 1.28 million shares, volume is running light vs its 52-week average. Headquartered in Audubon, PA, Globus Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Keith W. Pfeil, the company employs approximately 5,300 people and listed since August 03, 2012. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 7.49%, SMA50 7.15%, SMA200 37.95%). The stock’s 14-day RSI is 67.8 (firm momentum), while the ATR of 2.79 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -4.63% below its high and over 86.72% above its low. Average 10-day trading volume of 1.06 million shares is below the 3-month average of 1.26 million, indicating normal recent market interest.

Valuation Metrics

Globus Medical, Inc. trades at a P/E ratio of 22.09, slightly below the S&P 500 average, with a price-to-sales ratio of 4.05 and a price-to-book ratio of 2.6 suggesting the stock is closer to book value. The P/FCF stands at 20.55, also below market averages.

Dividend & Fair Value

Globus Medical, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $239.53. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Globus Medical, Inc. generated EPS of $3.93 over the past year. Five-year average earnings growth is 31.11%. Wall Street analysts project EPS growth of 10.8% annually over the next five years. The latest quarter delivered EPS of $1.18. The next quarter is forecast at $0.91. Next year's EPS is expected at $18.35. Analyst sentiment is bullish. Analyst rating data shows there are 10 Strong Buy ratings, 8 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $123.00 to $64.00. The high target offers 39.9% upside. The low target suggests -27.21% downside. The mean target is $96.70. This offers 9.99% upside. Globus Medical, Inc. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by 49.37%. The prior quarter beat by 13.16%. Over the last six quarters, Apple has recorded several small beats. These include 10.29% in August 06, 2024.

Shareholding & Insider Activity

Globus Medical, Inc. has 112.63 million shares outstanding. The public float is 111.73 million shares, elevated short interest at 4.76% of float. This equals 4.78 million shares. The short ratio is 2.94 days. Institutional investors hold 104.39% of the float. Insiders own 0.69%. Davidar David D holds 516.28 thousand shares, WHEELER KURT has 44.32 thousand shares and Murphy A Brett has 35.22 thousand shares. Over the past six months, insider transactions show net selling. They sold 125.64 thousand shares across 11 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Globus Medical generated $1.57B in revenue, or $13.68 per share. Gross margin was 65.05%, operating margin 8.49%, and net profit margin 7.83%. Returns are modest, with ROA at 2.42% and ROE at 3.07%.
On valuation metrics, Globus Medical trades at a P/E of 22.09, P/S of 4.05 and P/B of 2.60. The current ratio is 4.26 and quick ratio is 2.74. Operationally, the company’s inventory turnover is 1.26 and cash conversion cycle is 336.00 days. Debt-to-equity is 0.03, supported by a cash flow-to-debt ratio of 6.35.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Globus Medical posted revenue of $1.57B, down slightly from $1.02B in the prior quarter. Gross profit was $1.02B (margin 65.05%). Operating income was $133.14M (margin 8.5%). Net income was$122.87M (EPS $1.09).
The company ended the quarter with $517.79M in cash and short-term investments, a total debt of $520.40M, and net debt of $53.11M. Total assets were $5.09B, with equity of $4.00B. Financials further reflected stability, with operating cash flow of $243.50M, free cash flow of $165.23M, and capital expenditures of - $78.27M.

Price Forecast & Outlook

Our AI price prediction model suggests that Globus Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.93%, with price expected at $86.22 by April 16, 2026, within a range of $83.47 to $89.12 3-Month Outlook: Projected rise of 4.39%, reaching $91.78 by July 01, 2026, with a range of $89.54 to $94.37. 1-Year Outlook: Projected gain of 14.01%, with price at $100.24 by April 02, 2027, within a range of $96.13 to $105.00.

Key Takeaways

Globus Medical, Inc. (NYSE:GMED) shares are flat 6.46% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Globus Medical, Inc. trading at a premium to the broader market with a P/E of 22.09. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $79.83, suggesting -9.2% downside. Our AI forecast model points to short-term weakness (-1.93% over two weeks), a medium-term rise (4.39% over three months), and a longer-term gain (14.01% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Globus Medical, Inc. (GMED) stock price?

Globus Medical, Inc. (NYSE: GMED) stock price is $87.92 in the last trading session. During the trading session, GMED stock reached the peak price of $90.43 while $84.98 was the lowest point it dropped to. The percentage change in GMED stock occurred in the recent session was 0.21% while the dollar amount for the price change in GMED stock was $0.18.

GMED's industry and sector of operation?

The NYSE listed GMED is part of Medical - Devices industry that operates in the broader Healthcare sector. Globus Medical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GMED?

Mr. Mike Reeder
Executive Officer
Mr. Richard Holifield
Executive Officer
Mr. A. Brett Murphy
Executive Vice President of International Sales
Mr. Steven M. Payne
Vice President & Controller
Mr. John Dowling
Executive Officer
Mr. David C. Paul
Co-Founder & Executive Chairman
Ms. Kelly G. Huller Esq.
Senior Vice President, Gen. Counsel & Sec.
Mr. Brian J. Kearns
Senior Vice President of Bus. Devel. & Investor Relations
Mr. Daniel T. Scavilla
Pres, Chief Executive Officer & Director
Mr. Keith W. Pfeil
Senior Vice President & Chief Financial Officer

How GMED did perform over past 52-week?

GMED's closing price is 69.76% higher than its 52-week low of $51.79 where as its distance from 52-week high of $101.40 is -13.29%.

How many employees does GMED have?

Number of GMED employees currently stands at 5,300.

Link for GMED official website?

Official Website of GMED is: https://www.globusmedical.com

How do I contact GMED?

GMED could be contacted at phone 610 930 1800 and can also be accessed through its website. GMED operates from 2560 General Armistead Avenue, Audubon, PA 19403, United States.

How many shares of GMED are traded daily?

GMED stock volume for the day was 888.51K shares. The average number of GMED shares traded daily for last 3 months was 1.28M.

What is the market cap of GMED currently?

The market value of GMED currently stands at $11.89B with its latest stock price at $87.92 and 135.25M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	5300
Beta	1.07
Sales or Revenue	$1.57B
5Y Sales Change%	0.904%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

GMED Company Profile and Key Details

Globus Medical

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Technical Performance

Dividend & Fair Value

Valuation Metrics

Shareholding & Insider Activity

Key Takeaways

Price Forecast & Outlook

Company Overview